Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Mallinckrodt
Johnson and Johnson
Merck
Moodys

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Ravidasvir

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Ravidasvir: Sponsors, patents, clinical trial progress

Ravidasvir is an investigational drug.

There have been 8 clinical trials for Ravidasvir. The most recent clinical trial was a Phase 1 trial, which was initiated on September 1st 2016.

The most common disease conditions in clinical trials are Hepatitis C, Hepatitis, Chronic, and Hepatitis C, Chronic. The leading clinical trial sponsors are Ascletis Pharmaceuticals Co., Ltd., Drugs for Neglected Diseases, and Pharco Pharmaceuticals.

There are fifteen US patents protecting this investigational drug and two hundred and fifty-six international patents.

Recent Clinical Trials for Ravidasvir
TitleSponsorPhase
A Phase 1 Bioequivalence Study of a Test Tablet Formulation of Ravidasvir With the Reference Tablet Formulation of Ravidasvir StudyDrugs for Neglected DiseasesPhase 1
A Study to Evaluate the Pharmacokinetics and Safety of ASC16 Tablets in Healthy Volunteers in ChinaAscletis Pharmaceuticals Co., Ltd.Phase 1
Pharmacokinetics and Safety of Ravidasvir in Combination With Danoprevir/r in Healthy Volunteers ChinaAscletis Pharmaceuticals Co., Ltd.Phase 1

See all Ravidasvir clinical trials

Clinical Trial Summary for Ravidasvir

Top disease conditions for Ravidasvir
Top clinical trial sponsors for Ravidasvir

See all Ravidasvir clinical trials

US Patents for Ravidasvir

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Ravidasvir   Start Trial Antiviral compounds Gilead Sciences, Inc. (Foster City, CA)   Start Trial
Ravidasvir   Start Trial Antiviral compounds Gilead Sciences, Inc. (Foster City, CA)   Start Trial
Ravidasvir   Start Trial Inhibitors of HCV NS5A Presidio Pharmaceuticals, Inc. (San Francisco, CA)   Start Trial
Ravidasvir   Start Trial Antiviral compounds Gilead Sciences, Inc. (Foster, CA)   Start Trial
Ravidasvir   Start Trial Antiviral compounds Gilead Pharmasset LLC (Foster City, CA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Ravidasvir

Drugname Country Document Number Estimated Expiration Related US Patent
Ravidasvir African Regional IP Organization (ARIPO) 3622 2029-05-13   Start Trial
Ravidasvir Argentina 076765 2029-05-13   Start Trial
Ravidasvir Australia 2010249043 2029-05-13   Start Trial
Ravidasvir Brazil 122014012810 2029-05-13   Start Trial
Ravidasvir Brazil 122014013631 2029-05-13   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
AstraZeneca
Express Scripts
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.